Bob Bulleit

Promega (United States)

Papers

2

Total Citations

65

H-Index

2

About

Bob Bulleit is a biochemist whose research has made meaningful contributions to the field of enzyme assay development, particularly in the area of high-throughput screening technologies. His most recognized work centers on the design and implementation of innovative fluorogenic assays for studying protein kinases and phosphatases — two enzyme classes that play critical roles in cellular signaling and disease pathways. Bulleit's most influential contribution, a 2003 paper describing a homogeneous, nonradioactive fluorogenic protein kinase assay, has garnered 49 citations and represents a significant methodological advance in the field. By moving away from traditional radioactive detection methods, his approach offered researchers a safer, more scalable, and equally sensitive alternative for measuring kinase activity in high-throughput formats. Building on this work, his 2004 follow-up paper extended the same elegant strategy to protein phosphatase assays, further broadening the toolkit available to biochemists and drug discovery scientists. Together, these contributions reflect Bulleit's commitment to developing practical, laboratory-ready tools that enable researchers to study enzyme function more efficiently — work that continues to inform both basic research and pharmaceutical screening pipelines.

Research Focus

Key Achievements

2
H-Index
2
Papers
65
Total Citations
33
Avg Citations/Paper
🏆 Most Cited Paper
A homogeneous, nonradioactive high-throughput fluorogenic protein kinase assay
49 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Promega (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago